4//SEC Filing
Bronstein Ben 4
Accession 0000950170-23-031781
CIK 0001341235other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:34 PM ET
Size
10.0 KB
Accession
0000950170-23-031781
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-30+21,222→ 21,222 totalExercise: $8.39Exp: 2033-06-29→ Common Stock (21,222 underlying) - Award
Stock Option (Right to Buy)
2023-06-30+1,372→ 1,372 totalExercise: $8.39Exp: 2033-06-29→ Common Stock (1,372 underlying) - Award
Stock Option (Right to Buy)
2023-06-30+1,464→ 1,464 totalExercise: $8.39Exp: 2033-06-29→ Common Stock (1,464 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001604458
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:34 PM ET
- Size
- 10.0 KB